StockData
Pfizer Inc logo

Pfizer Inc

PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Aug 4, 2026Score 11/3056% above fair value
$30.52+0.57 (+1.90%)

Close on Oct 30, 2026Market cap $173.95BP/E 40.2Yield 5.64%

Pfizer Pfizer CentreOne (Contract Development & Manufacturing by Year

Pfizer CentreOne (Contract Development & Manufacturing Organization — CDMO) — U.S. reported YoY (%) (%)

QuarterlyAnnual

Pfizer Pfizer CentreOne (Contract Development & Manufacturing: 18.0% in FY2025, up 39.0 pts from a year earlier.

Latest, FY2025
18.0%
Period ended Dec 31, 2025
Change on a year earlier
+39.0 pts
-21.0% in FY2024
History
9 years
Since FY2017
Sources
9
Documents cited below

Where the FY2025 figure comes from

“|| PFIZER CENTREONE (j) | $ | 1,338 | $ | 1,146 | 17% | 15% | $ | 329 | $ | 278 | 18% | $ | 1,010 | $ | 868 | 16% | 15%”

Source: Form 8-K (Earnings / Guidance Release) (pfe-12312025xex99.htm, filed 2026-02-03) ↗

Reported in Form 8-K Revenue Tables.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedPfizer CentreOne (Contract Development & Manufacturing Organization — CDMO) — U.S. reported YoY (%) (%)Year on yearSource
FY2025Dec 31, 202518.0%+39.0 ptsForm 8-K (Earnings / Guidance Release) (pfe-12312025xex99.htm, filed 2026-02-03) ↗
FY2024Dec 31, 2024-21.0%-18.0 ptsForm 8-K (Earnings / Guidance Release) (pfe-12312024xex99.htm, filed 2025-02-04) ↗
FY2023Dec 31, 2023-3.0%+16.0 ptsForm 8-K (Earnings / Guidance Release) (pfe-12312023xex99.htm, filed 2024-01-30) ↗
FY2022Dec 31, 2022-19.0%-246.0 ptsForm 8-K (Earnings / Guidance Release) (pfe-12312022xex99.htm, filed 2023-01-31) ↗
FY2021Dec 31, 2021227.0%+133.0 ptsForm 8-K (Earnings / Guidance Release) (pfe-12312021xex99.htm, filed 2022-02-08) ↗
FY2020Dec 31, 202094.0%+82.0 ptsForm 8-K (Earnings / Guidance Release) (pfe-12312020xex99.htm, filed 2021-02-02) ↗
FY2019Dec 31, 201912.0%+36.0 ptsForm 8-K (Earnings / Guidance Release) (pfe-12312019xex99.htm, filed 2020-01-28) ↗
FY2018Dec 31, 2018-24.0%-28.0 ptsForm 8-K (Earnings / Guidance Release) (pfe-12312018xex99.htm, filed 2019-01-29) ↗
FY2017Dec 31, 20174.0%–Form 8-K (Earnings / Guidance Release) (pfe-12312017xex99.htm, filed 2018-01-30) ↗

Cite this data

StockData. (2026). Pfizer Pfizer CentreOne (Contract Development & Manufacturing (%), annual FY2017–FY2025 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/pc1-yoy-us

See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.